2nd virus vaccine shows overwhelming success in U.S. tests
The company said its vaccine appears to be 94.5% effective, according to preliminary data from Moderna's ongoing study.
The company said its vaccine appears to be 94.5% effective, according to preliminary data from Moderna's ongoing study.